FDA 483 - Abbott Medical - August 02, 2019

Abbott/St. Jude Medical Inc. in Sylmar, CA, a medical device manufacturer, was cited for three observations during an FDA inspection. The firm failed to adequately control non-conforming products, exhibited inadequate risk analysis for implanted devices, and did not report a significant field correction to the FDA. These issues relate to pacemakers and programmer software updates.